From WaVe Gets $18M to Solve RNA’s “Underappreciated” Chemistry Problem:

WaVe-Logo—

Boston- and Japan-based WaVe Life Sciences is developing RNA drugs.

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
Bridging the Diversity Gap with Decentralized Trials
How a patient-centric, technology-driven approach can broaden access to research and reach patients regardless of geography, ethnicity, sex, or gender
PRA Health Sciences

Sponsored · Whitepaper
How to Approach Life Sciences Fundraising
Explore the different sources of funding, their relative merits, and how you should best utilize that funding at each stage of your research
Brex

Sponsored · Video
Fish & Richardson: Patent Law in Regards to AI and Machine Learning
A Fireside Chat with Fish & Richardson Principal Teresa Lavoie
Fish & Richardson

Xconomy on Demand

We offer a number of ways to subscribe for free!